Luts & Greenleigh Group, Inc Abbott Laboratories Transaction History
Luts & Greenleigh Group, Inc
- $79.3 Billion
- Q4 2023
A detailed history of Luts & Greenleigh Group, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Luts & Greenleigh Group, Inc holds 13,765 shares of ABT stock, worth $1.41 Million. This represents 1.91% of its overall portfolio holdings.
Number of Shares
13,765
Previous 14,009
1.74%
Holding current value
$1.41 Million
Previous $1.36 Billion
11.67%
% of portfolio
1.91%
Previous 1.68%
Shares
5 transactions
Others Institutions Holding ABT
# of Institutions
3,130Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$16.9 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.6 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.59 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.65 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.18 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $179B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...